Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 4Breast Neoplasms 4Myeloproliferative Disorders 3Melanoma 3Skin Neoplasms 2Lung Neoplasms 2Thrombosis 1Pyruvate Kinase Deficiency of Red Cells 1Precancerous Conditions 1Pancreatic Cyst 1Neuroendocrine Tumors 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Myelitis, Transverse 1Myasthenia Gravis 1Multiple Sclerosis 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lymphatic Metastasis 1Locally Advanced Head and Neck Carcinoma 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Esophageal Neoplasms 1Endometrial Neoplasms 1Diagnosis of Cancer of Various Organs 1Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

Cyclophosphamide 13Rituximab 11obinutuzumab 6fludarabine phosphate 6Prednisone 6Magnetic Resonance Spectroscopy 6ibrutinib 5fludarabine 5X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Melphalan 5Lenalidomide 5Etoposide 5Doxorubicin 5Biopsy 5tocilizumab 4Whole-Body Irradiation 4venetoclax 3polatuzumab vedotin 3glofitamab 3acalabrutinib 3Vincristine 3Mycophenolic Acid 3Leukapheresis 3Filgrastim 3Cytarabine 3Cyclosporine 3Busulfan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × Blood Specimen Collection × 30 days × Clear all
NCT07588698 2026-05-15

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡